Company Filing History:
Years Active: 2010
Title: Innovator in Alzheimer's Research: Takahiro Suemoto
Introduction: Takahiro Suemoto is an accomplished inventor located in Wako, Japan. He has made significant contributions to the field of Alzheimer's disease research, with a focus on developing innovative models to better understand the pathology of this complex condition.
Latest Patents: Suemoto holds a noteworthy patent titled "Model mouse of Alzheimer's disease expressing FAD APP 716 and use thereof." This invention presents a non-human mammalian model of Alzheimer's disease, equipped with a chimeric amyloid precursor protein (APP) gene. This gene allows the creation of human amyloid β peptide (Aβ), exhibiting a significantly elevated Aβ42/Aβ40 ratio, which is crucial in Alzheimer's research. The model provides a valuable tool for early diagnosis and the screening of drugs for the prevention and treatment of Alzheimer's disease.
Career Highlights: Takahiro Suemoto is currently affiliated with RIKEN Corporation, a leading research institution in Japan. His groundbreaking work in developing a precise model for studying Alzheimer's disease showcases his commitment to advancing scientific knowledge in this critical area of health.
Collaborations: Throughout his career, Suemoto has collaborated with esteemed colleagues such as Takaomi Saido and Nobuhisa Iwata. These collaborations further amplify the impact of his work and enhance the collective efforts in tackling the challenges posed by Alzheimer's disease.
Conclusion: Takahiro Suemoto is a pioneering inventor whose contributions to Alzheimer's disease research are of great significance. His patent for a novel model mouse serves as a critical resource for the scientific community, enabling advancements in understanding and combating this devastating condition.